Kövesi G, Mohari K, Kocsár L, Fekete B, Szilvási I, Szabó G
Department of Maxillofacial Surgery, Semmelweis University of Medicine, Budapest, Hungary.
Strahlenther Onkol. 1991 Jul;167(7):434-8.
Monoclonal antibody was prepared against myelin basic protein a so-called pancarcinoma antigen. After labelling with 131I the monoclonal antibody was injected into Lewis-lung cancer mice and rats with Walker breast cancer. Two, 24, 48, 72 and 96 hours after the labelled monoclonal antibody injection, radioimmunoimaging studies were carried out. After each gamma-camera study, organ distribution of the labelled monoclonal antibody was determined with radiobioassay technique which showed significantly higher activity in the tumour tissue than in healthy ones. Significant sample radioactivity could be recovered in the tumour masses 48 hours after injection, which persisted even after 96 hours. The later finding might enable diagnosing types of malignancy with isotope-labelled monoclonal antibody against myelin basic protein.
制备了针对髓磷脂碱性蛋白(一种所谓的泛癌抗原)的单克隆抗体。用¹³¹I标记后,将单克隆抗体注射到患有Lewis肺癌的小鼠和患有Walker乳腺癌的大鼠体内。在注射标记的单克隆抗体后的2、24、48、72和96小时,进行放射免疫显像研究。每次γ相机研究后,用放射生物测定技术测定标记单克隆抗体的器官分布,结果显示肿瘤组织中的活性明显高于健康组织。注射后48小时,肿瘤块中可回收大量样品放射性,甚至在96小时后仍持续存在。这一发现可能有助于用针对髓磷脂碱性蛋白的同位素标记单克隆抗体诊断恶性肿瘤类型。